Clover Health Investments, Corp. /De (CLOV)
| Market Cap | 2.32B+61.3% |
| Revenue (ttm) | n/a+54.0% |
| Net Income | n/a+57.4% |
| EPS | n/a+52.2% |
| Shares Out | 518.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,292,858.773 |
| Open | 4.50 |
| Previous Close | 4.56 |
| Day's Range | 4.44 - 4.54 |
| 52-Week Range | 1.58 - 5.59 |
| Beta | n/a |
| Analysts | Hold |
| Price Target | 5.50(+22.63%) |
| Earnings Date | n/a |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About CLOV
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CLOV stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in CLOV holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CLOV's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CLOV Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CLOV Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Premiums earned, net (net of ceded premiums) | $737.77M | 55.33% |
| Net medical claims incurred | $590.16M | 44.26% |
| Other income | $5.40M | 0.41% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CLOV patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CLOV from public contracts
Source: USAspending.gov
CLOV Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CLOV’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score